Succeeding 13 years of R&D with a commercial-level rare disease drug, Sarepta Therapeutics, Inc. (NASDAQ:SRPT) tees up to deliver on the latter half of its promise to provide the world with a DMD cure for sufferers that may be amenable to Exon 51 skipping, and otherwise. A result that would facilitate the first cure for DMD and sizable growth potential.
“Mors tua, vita mea” (literally “your death is my life) probably was the motto that gladiators, in the ancient Rome, recited before entering in the Coliseum and fighting for their life. Over and above its literal translation, this Latin expression means that what is a damage for one person is often an advantage for another. There can only be one winner in a competition; that is....More>>>
EMM & QNX will be the growth drivers going forward. But the risks in BlackBerry stock continue to remain elevated.
BlackBerry(NSDQ:BBRY)stock is a very volatile stock. When the company announced its latest set of earnings on the 20th of December, the share price rose to around $8 a share, but since then has plummeted back down to the $7 level. Blackberry is unique in that it is a low....More>>>
Overall, stocks did well on Monday, and the Dow climbed 90 points even as other major benchmarks posted similar or slightly larger percentage gains. Market participants seemed to be heartened by President Trump’s performance on the first overseas visit of his administration over the weekend, and most investors were content to wait for clearer gauges of whether the U.S. economy is....More>>>
The travails and triumphs of the market visited two of its mavens this week, when a PR fiasco sunk Warren Buffett (Trades, Portfolio) stock United Airlines and an unlikely burst occurred in one of Prem Watsa (Trades, Portfolio)’s most stubborn stocks, BlackBerry.
Shares of United Continental Holdings dropped 4.29% on Monday and Tuesday, shaving $88.9 million off of Buffett’s holding....More>>>
Steven Mnuchin could soon be signing your money, so it’s kind of a big deal that his signature is illegible.
President-elect Trump has picked Mnuchin to replace Jack Lew as the next Treasury secretary. If the Senate approves his Cabinet pick, then Mnuchin’s signature will appear in the lower right corner of newly printed currency.
Biotech stocks are having a great day today–iShares Nasdaq Biotechnology ETF (IBB) has climbed 2.5% to $276.92–leading some to suggest that 2017 could be better for investors than 2016 was. Not Baird’s Brian Skorney and Michael Ulz, who “don’t think 2017 will be worse than 2016″ but “aren’t quite sure it will be much better.” They explain....More>>>
We're in the thick of earnings season, which means some of the most prominent industry leaders are set to report their quarterly results. Tomorrow morning, Israel-based drug developer Teva Pharmaceutical Industries (NYSE:TEVA) is set to join the crowd and release its first-quarter financial resul
When it comes to retirement income bond ladders, Joe Tomlinson created a taxonomy of different types in his 2014 Advisor Perspectives column, “Why the Risk Reduction Benefits of Bond Ladders Have Been Overstated.” His list inspired me to create a more extended vers
The stock market finished mixed on Tuesday, and although the Dow Jones Industrials still finished with a loss of more than 100 points, other major market benchmarks finished very close to the unchanged level on the day. Geopolitical pressure continued to hurt investor sentiment, and some bad
Biotech stocks are having a great day today–iShares Nasdaq Biotechnology ETF (IBB) has climbed 2.5% to $276.92–leading some to suggest that 2017 could be better for investors than 2016 was. Not Baird’s Brian Skorney and Michael Ulz, who “don’t think 2017 will be